An AI model spotted a strange pattern in a virus's DNA that looks a little like CRISPR. Its makers cannot yet say what it ...

Application of the high-precision technique is part of a clinical trial to treat a genetic disease that can cause liver and ...

ERS Genomics Limited ('ERS Genomics'), the CRISPR licensing company, today announced that it has signed a non-exclusive ...

CRISPR Therapeutics (NasdaqGM:CRSP) has promoted Andrew J. Silver to Chief Financial Officer, effective October 19, 2026.

CFO recently resigned, potentially signaling that CRSP stock could be heading for a downturn. Further, the shares are ...

A 2026 review summarizes advances in CRISPR-Cas9 precision, delivery and primary-cell engineering for genetic diseases and ...

Japanese researchers used CRISPR-Cas9 to remove the extra chromosome 21 from cells in a lab. It's a real breakthrough — but not a Down syndrome cure, and not a new 2026 treatment.

An integrated alfalfa tissue-culture system produced faster regeneration and transformation, with a 2.8-fold increase in ...

An ancient viral insertion silences LINC00662 in chimpanzee cells, while the gene is active during early human brain ...

Spread the loveImagine looking in the mirror and seeing a younger version of yourself, not just cosmetically, but at a ...

A decade ago, Ying Zhang found herself on the cusp of a medical revolution. CRISPR crops are coming to Europe — why bolder would be better Zhang was one of the first scientists to be hired by CRISPR ...

CRISPR Therapeutics (Nasdaq: CRSP) today announced that clinical data from the Phase 1b trial of CTX310®, its investigational CRISPR/Cas9 in vivo gene editing therapy targeting angiopoietin-related ...